Financial News
Headline News about CG Oncology, Inc. - Common stock
![](https://cdn.benzinga.com/files/images/story/2024/12/11/25.png?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2024/december/mmc/mmc-dec11.png?sfvrsn=7efea306_2)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Demystifying CG Oncology: Insights From 7 Analyst Reviews
December 06, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/12/05/CGON.png?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20241105113016_discover-the-3-best-performing-biotech-ipo-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Decoding 10 Analyst Evaluations For CG Oncology
May 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/10/24/Analysts.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/03/Movers_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/03/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/03/Amgen-stock_0.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/03/A1-040124-IPOpipeline-shutt.jpg)
![](https://g.foolcdn.com/editorial/images/765388/scientists-confer-at-lab-bench.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/12/image37.jpeg?width=1200&height=800&fit=crop)
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://live.staticflickr.com/4865/32641567148_2fc9c5ea06_n.jpg)
KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower
January 28, 2024
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.